SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-073875
Filing Date
2023-03-17
Accepted
2023-03-17 16:11:33
Documents
6
Effectiveness Date
2023-03-17

Document Format Files

Seq Description Document Type Size
1 S-8 d478618ds8.htm S-8 44667
2 EX-5.1 d478618dex51.htm EX-5.1 9503
3 EX-23.2 d478618dex232.htm EX-23.2 1210
4 EX-99.3 d478618dex993.htm EX-99.3 8009
5 EX-FILING FEES d478618dexfilingfees.htm EX-FILING FEES 24455
6 GRAPHIC g478618dsp6.jpg GRAPHIC 2233
  Complete submission text file 0001193125-23-073875.txt   92111
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270651 | Film No.: 23742674
SIC: 2836 Biological Products, (No Diagnostic Substances)